The CRISPR and Beyond: Perturbations at Scale to Understand Genomes (28-30 September 2022) hybrid conference is open for registration and abstract submissions.

The fourth meeting in this series will focus on how advances in gene-editing technology and DNA synthesis are making it possible to modulate genomes with ease.

Join a community of international biomedical researchers to explore the emerging technologies and models (including computational approaches) that are enabling enhanced precision medicine for heritable diseases and cancer treatment.

Hear from our expert-speakers on the functional implications of natural and disease-related human genetic variation, and how this affects the application of CRISPR/Cas-based functional genomics in identifying new drug targets.

Discuss a variety of exciting topics:
– Emerging technologies and models
– Computational models
– Controlling transcription
– Protein engineering
– Highly parallel readouts
– Precision editing
– Functional genomics in drug discovery (panel discussion)

If you have research to share, we are accepting abstract submissions on any of these key areas.

Receive feedback from – and network with – experts in the fields of high throughput screening, genome engineering, and variant effect interpretation; forming connections with the potential to advance your research, and your career.

Register here: https://email.wellcomeconnectingscience.org/6Y2C-52PG-1GUFG5-2SAJI-1/c.aspx

Key dates: Abstract and bursary deadline: 2 August 2022 Registration deadline (in-person): 30 August 2022 Registration deadline (virtual): 20 September 2022 Scientific committee: John DoenchBroad Institute of MIT and Harvard, USA Jolanda van LeeuwenUniversity of Lausanne, Switzerland Leopold PartsWellcome Sanger Institute, UK Lea StaritaUniversity of Washington, USA